Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of TNFRSF8 mRNA | affects expression | 16483693
|
D001151 |
Arsenic |
Arsenic results in increased expression of TNFRSF8 mRNA | increases expression | 19962721
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of TNFRSF8 mRNA | decreases expression | 19730151
|
D002392 |
Catechin |
Catechin results in decreased expression of TNFRSF8 mRNA | decreases expression | 15465739
|
D003513 |
Cycloheximide |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of TNFRSF8 mRNA] | decreases reaction|increases expression | 11007951
|
D005665 |
Furosemide |
Furosemide affects the expression of TNFRSF8 mRNA | affects expression | 17497460
|
D007530 |
Isoflurane |
Isoflurane results in decreased expression of TNFRSF8 mRNA | decreases expression | 16978161
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of TNFRSF8 mRNA | increases expression | 12057914
|
D005996 |
Nitroglycerin |
Nitroglycerin results in decreased expression of TNFRSF8 mRNA | decreases expression | 12102619
|
C006253 |
pirinixic acid |
NCF1 protein promotes the reaction [pirinixic acid results in decreased expression of TNFRSF8 mRNA] | decreases expression|increases reaction | 17950772
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of TNFRSF8 mRNA | decreases expression | 17950772
|
D013749 |
Tetrachlorodibenzodioxin |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of TNFRSF8 mRNA] | decreases reaction|increases expression | 11007951
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TNFRSF8 mRNA | increases expression | 11007951
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TNFRSF8 mRNA | increases expression | 18684927 15310856 14718646
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.04 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.75 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
9.55 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
9.55 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
2.31 | 11798837 19825857 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.56 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.56 | 16835633 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.43 | 17306315 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.08 | 11748828 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.90 | 16835338 12569548 16251483 18414634 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.33 | 19371607 12928151 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
16.12 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
16.12 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
16.12 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.01 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.85 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.69 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.48 | 11589617 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.91 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.66 | 17687452 15504454 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
3.28 | 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
3.28 | 14691202 11135700 15073043 16217749 15553829 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.09 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.25 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
2.72 | 15504454 17687452 18922899 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.21 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.44 | 18670907 18850075 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.54 | 15738583 19152805 17938729 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.43 | 18022660 16973168 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.93 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.15 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.18 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.35 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.51 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.51 | 20055451 10048152 15322242 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.24 | 15213294 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.48 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.57 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.86 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Furosemide |
5.16 | 16935035 |
MESH:D004487 |
Edema |
|
Furosemide |
12.35 | 11834646 |
MESH:D004487 |
Edema |
|
pirinixic acid |
12.35 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
12.35 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.12 | 18230668 15322242 16714409 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.15 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.59 | 17637181 15821434 15328337 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
2.34 | 12903497 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.12 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
8.19 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.19 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.63 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
4.14 | 11852909 9205823 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.12 | 20067830 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.78 | 6392382 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.42 | 16904648 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.81 | 10696789 |
MESH:D006261 |
Headache |
|
Nitroglycerin |
5.41 | 11554966 11284996 |
MESH:D034381 |
Hearing Loss |
|
Furosemide |
4.95 | 17868369 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.40 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
Furosemide |
7.59 | 16011733 12660669 16845234 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.59 | 20558911 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.52 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.48 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.85 | 19772884 19176532 16221962 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.85 | 12621046 16120746 15340226 |
MESH:D006689 |
Hodgkin Disease |
marker/mechanism |
|
| 12453859 16879607 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.26 | 16959395 15340226 8697196 18606429 16354765 |
MESH:D006934 |
Hypercalcemia |
|
Furosemide |
5.21 | 17652376 |
MESH:D053565 |
Hypercalciuria |
|
Furosemide |
5.85 | 17652376 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.31 | 20558911 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Catechin |
5.10 | 17292331 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.59 | 17050553 |
MESH:D006962 |
Hyperparathyroidism, Secondary |
|
Furosemide |
6.09 | 15086907 |
MESH:D006973 |
Hypertension |
|
Arsenic |
5.39 | 16076760 11953799 9931084 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.39 | 18670907 18850075 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Furosemide |
5.46 | 16612254 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.78 | 16093927 |
MESH:C537153 |
Hypomagnesemia primary |
|
Furosemide |
5.85 | 11041285 |
MESH:D007019 |
Hypoproteinemia |
|
Furosemide |
6.09 | 16096441 |
MESH:D007022 |
Hypotension |
|
Furosemide |
10.37 | 11041285 |
MESH:D007022 |
Hypotension |
|
Isoflurane |
10.37 | 12967683 |
MESH:D007024 |
Hypotension, Orthostatic |
|
Furosemide |
5.63 | 15811171 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
5.30 | 17237260 9205823 17963957 12878042 17255318 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.30 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.72 | 16306350 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.78 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.48 | 16580747 |
MESH:D007642 |
Keratosis |
|
Arsenic |
5.18 | 12749816 16930632 |
MESH:D007674 |
Kidney Diseases |
|
Furosemide |
3.85 | 11041285 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.89 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.93 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.50 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.53 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.90 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.16 | 16467208 19850784 17050201 16968895 20471514 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
8.08 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
8.08 | 12712474 16112521 19075265 12018890 17649720 19035177 17712046 16330433 19642359 16331271 17869043 15748426 15213294 15336539 16891316 17217047 9834237 11468182 12679006 17107899 11161223 15622746 16966277 19225113 16823087 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.51 | 16882451 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.89 | 15821434 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
3.53 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.53 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.53 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.57 | 11134558 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
11.10 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
11.10 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
11.10 | 15890375 16377806 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
11.10 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
6.08 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.08 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.46 | 15213294 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
4.18 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
3.52 | 17306315 19168569 17976673 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
3.52 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.52 | 19555203 11884234 |
MESH:D008708 |
Methemoglobinemia |
|
Nitroglycerin |
4.88 | 3537620 |
MESH:D020326 |
Migraine without Aura |
|
Nitroglycerin |
5.29 | 14659530 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.20 | 19417148 11468182 15949261 19549372 14977855 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.68 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.89 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.22 | 16882451 16105982 |
MESH:D009203 |
Myocardial Infarction |
|
Nitroglycerin |
6.19 | 14729435 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
6.19 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
9.38 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.38 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.05 | 16411023 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.12 | 16624393 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.01 | 17405874 |
MESH:D009397 |
Nephrocalcinosis |
|
Furosemide |
6.09 | 15086907 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.37 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
7.74 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
7.74 | 10525206 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.52 | 17056641 |
MESH:D053206 |
Nocturnal Enuresis |
|
Furosemide |
6.09 | 17945291 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
5.15 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
5.15 | 16624393 12452020 19769630 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.57 | 15580305 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.31 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.47 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.34 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
5.18 | 15371236 16905509 6392382 |
MESH:D010538 |
Peritonitis |
|
Isoflurane |
5.40 | 17414419 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.75 | 12224865 11605937 |
MESH:D011141 |
Polyuria |
|
Furosemide |
5.85 | 17945291 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.72 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.38 | 11118676 11399792 11222880 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
3.38 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
3.38 | 19131511 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
4.15 | 21343184 |
MESH:D015427 |
Reperfusion Injury |
|
Furosemide |
7.02 | 16526316 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
7.02 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Furosemide |
4.76 | 15912074 16096441 12394941 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.82 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.00 | 18990726 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.12 | 16646077 |
MESH:D018805 |
Sepsis |
|
Isoflurane |
5.11 | 17414419 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.78 | 17938729 15952646 6392382 17548696 16353154 18709164 19834688 17453740 17050553 16702368 16759981 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
5.91 | 19538983 16251483 15504454 17029826 17976673 17050553 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.91 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.88 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Furosemide |
2.88 | 17052386 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.30 | 15821434 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.12 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
3.19 | 19014326 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.15 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
5.44 | 17976673 19322015 15987713 11144890 18640142 19429237 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
5.44 | 11780464 12845720 20435036 12973940 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.93 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.81 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.47 | 15886252 |